Medical Devices

  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes

    New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

    By • Feb. 13, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers, Mayo Clinic partner on neurodegenerative disease, cancer

    An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.

    By • Feb. 13, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Novocure wins FDA approval to treat pancreatic cancer with electric fields

    Winning approval to target the 15,000 U.S. patients with locally advanced pancreatic cancer is the first step in a broader expansion in the tumor type.

    By • Feb. 13, 2026
  • The CEO of Neurent Medical displays the Neuromark device with laboratory equipment in the background.
    Image attribution tooltip
    Courtesy of Neurent Medical
    Image attribution tooltip

    Neurent raises $74M to commercialize treatment for nasal condition

    The device creates lesions to disrupt nerve signals that drive mucus production.

    By • Feb. 12, 2026
  • A portrait of Melissa Torres.
    Image attribution tooltip
    Permission granted by AdvaMed
    Image attribution tooltip

    AdvaMed names Melissa Torres as new leader for technology and regulatory affairs

    Torres joins the medtech lobby from the FDA’s Center for Devices and Radiological Health, where she was associate director for international affairs.

    By • Feb. 12, 2026
  • Professional photo of Ivan Tornos
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer plans US salesforce reorganization

    Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.

    By • Feb. 11, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards focuses on earlier TAVR adoption

    The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.

    By • Feb. 11, 2026
  • A person wearing gloves hangs a clear bag with fluid on a metal hook.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene

    Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.

    By • Feb. 10, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker starts limited release of Mako RPS handheld knee robot

    Surgeons interested in robotic technology but wanting a simpler system than existing platforms are the target market for the new device.

    By • Feb. 10, 2026
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA breakthrough program starts FY2026 at steady pace

    Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.

    By • Feb. 9, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J recalls coil systems used in aneurysm treatment

    Healthcare providers are advised to stop using the devices after a failure to detach was linked with four serious injuries and one death.

    By • Feb. 6, 2026
  • Shipping containers of varying colors stacked on a ship.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    GE HealthCare expects smaller tariff impact in 2026

    After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate their effects in 2026, including shifting its supply chain.

    By • Feb. 5, 2026
  • Medtronic's MiniMed 780G
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins expanded FDA label for 780G insulin pump

    The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

    By • Feb. 5, 2026
  • A tan and black monument sign with bold orange "Optum" lettering and the address "11000 Optum Circle" sits on a grassy lawn with low shrubs in front of a large, modern office building with glass windows and beige panels. Bare trees and a cloudy sky are in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Prices rise at surgery centers acquired by Optum: study

    The full financial impact of the price hikes could exceed $67 million each year in two dozen markets, according to the new study published in Health Affairs.

    By Rebecca Pifer Parduhn • Feb. 4, 2026
  • Illustration of a heart with a metal, coiled wire going into it.
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    J&J corrects Impella heart pumps over issue linked to 22 serious injuries

    The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.

    By • Feb. 4, 2026
  • Medicare enrollment form and money.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Genetic testing takes greater share of Medicare Part B test spending: OIG

    Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.

    By • Feb. 4, 2026
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott receives FDA warning letter over Freestyle Libre CGMs

    Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.

    By • Feb. 3, 2026
  • The CathWorks FFRangio System on a cart.
    Image attribution tooltip
    Permission granted by CathWorks
    Image attribution tooltip

    Medtronic to acquire CathWorks for up to $585M

    The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.

    By • Feb. 3, 2026
  • new cfo appointments
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    STAAR names interim co-CEOs amid search for permanent leader

    The company is looking for a new top executive after former CEO Stephen Farrell left when STAAR shareholders rejected a buyout offer from Alcon.

    By • Feb. 3, 2026
  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics receives FDA warning letter

    The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute products, the company said.

    By • Feb. 2, 2026
  • A person wearing a suit sits at a table.
    Image attribution tooltip
    Chip Somodevilla via Getty Images
    Image attribution tooltip

    Lawsuit challenges ethylene oxide exemptions for device sterilizers

    The lawsuit questions the Trump administration’s authority to make sweeping environmental exemptions without evidence.

    By • Feb. 2, 2026
  • Four robots side by side with a single arm have different instruments attached to the end.
    Image attribution tooltip
    Courtesy of Stryker
    Image attribution tooltip

    Stryker starts first cases with handheld ortho robot

    Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

    By • Jan. 30, 2026
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics wins CE mark for one-year CGM

    The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

    By • Jan. 30, 2026